These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 845443)

  • 1. The estimation of lymphotoxic activity of ALS by spectrophotometric method.
    GoĊ›cicka T; Rudnicka W; Tarabasz L
    J Immunol Methods; 1977; 15(1):9-15. PubMed ID: 845443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A spectrophotometric quantitation of cytotoxic action of antiserum and complement by trypan blue.
    Saijo N
    Immunology; 1973 Apr; 24(4):683-90. PubMed ID: 4706564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to cell surface antigens detected by a rapid spot test using ethidium bromide.
    Cohn ML; Golding H; Rittenberg MB
    J Immunol Methods; 1982; 49(1):75-82. PubMed ID: 6174640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T-cell receptor and cytotoxicity An anti=idiotype antiserum that inhibits a graft-versus-host reaction does not inhibit cell-mediated cytotoxicity.
    Braun M; Saal F
    Cell Immunol; 1977 May; 30(2):254-60. PubMed ID: 16699
    [No Abstract]   [Full Text] [Related]  

  • 5. Further evaluation of 86rb in lymphocyte cytotoxicity.
    Chollet P; Gauvin H; Bidet JM; Chassagne J; Vuillaume C; Plagne R
    Transplantation; 1976 Aug; 22(2):212-4. PubMed ID: 968937
    [No Abstract]   [Full Text] [Related]  

  • 6. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells.
    Lamon EW; Whitten HD; Skurzak HM; Andersson B; Lidin B
    J Immunol; 1975 Nov; 115(5):1288-94. PubMed ID: 1080777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Qa-2 antigen on lymphocyte subpopulations. Mixed lymphocyte culture and cell-mediated lympholysis.
    Sullivan KA; Flaherty L
    J Immunol; 1979 Dec; 123(6):2920-4. PubMed ID: 159324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antilymphocyte globulin for leukemia induction in mice.
    Radzikowski C; Szkudlarek J; Czarnomska A; Steuden J; Krajewski L
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):697-711. PubMed ID: 793567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the protective action of diphosphonic compounds against a T-lymphocyte lesion by antilymphocyte serum].
    Zernov IN; Stefani DV; Vel'tishchev IuE
    Biull Eksp Biol Med; 1979 Mar; 87(3):259-60. PubMed ID: 311661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular differentiation in the thymus. IV. Response of rat thymic subpopulations to anti-thymus serum and other nonspecific mitogens.
    Wu AY; Waksman BH
    Cell Immunol; 1972 Mar; 3(3):516-28. PubMed ID: 4552095
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antilymphocyte serum. Effects on blastogenesis and cytotoxic activity of lymphocytes stimulated with phytohemagglutinins].
    Tursi A; Trizio D; Ferrannini A
    Folia Allergol (Roma); 1971; 18(2):191-4. PubMed ID: 5165171
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of heterologous anti-mouse lymphocyte serum (ALS) in studies of tumorogenic potentials of C3H murine cells propagated in vitro.
    Radzikowski C; Kieler J
    Arch Immunol Ther Exp (Warsz); 1972; 20(4):473-84. PubMed ID: 5078889
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions of antibodies and effector cells in immunity against tumours.
    Allison AC
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):619-31. PubMed ID: 5050872
    [No Abstract]   [Full Text] [Related]  

  • 14. Mouse bone marrow lymphocytes and their differentiation.
    Ryser JE; Vassalli P
    J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversal by the MER tubercle bacillus fraction of the suppressive effects of heterologous antilymphocytic serum (ALS) on the allograft reactivity of mice.
    Kuperman O; Feigis M; Weiss DW
    Cell Immunol; 1973 Sep; 8(3):484-9. PubMed ID: 4199204
    [No Abstract]   [Full Text] [Related]  

  • 16. An experimental system for the simultaneous estimation of mitostatic and lymphotoxic effects of immunosuppressants and cytostatics.
    Petrov RV; Manyko VM; Khaitov RM; Seslavina LS
    J Exp Med; 1971 Mar; 133(3):640-8. PubMed ID: 4398741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic cells suppress in vitro generation of cellular immunity by stimulator cell lysis.
    Sugarbaker PH; Matthews W
    Cell Immunol; 1981 Jan; 57(1):124-35. PubMed ID: 6452212
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitation of cytotoxic rat antibodies by post-assay labeling of mitogen-induced target blasts with [3H]thymidine.
    Martinelli GP; Blumenthal D; Schanzer H
    J Immunol Methods; 1984 Feb; 67(1):53-61. PubMed ID: 6607958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial purification and characterization of a lymphotoxic factor from multiple sclerosis serum.
    White G; Armentrout S; van den Noort S
    Neurology; 1975 Jan; 25(1):37-42. PubMed ID: 1078607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro analysis of immune reactivity in ALS-treated, bone marrow injected mice bearing enhanced skin allografts.
    Maki T; Gottschalk R; Homsy FN; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):596-8. PubMed ID: 6455803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.